Marjorie Shulman
Share |

 

Marjorie Shulman 

Chief of Premarket Notification (510(k)) Section, Center for Devices and Radiological Health, Food & Drug Administration

Marjorie Shulman is the Director for the Premarket Notification (510(k)) Program in the Office of Device Evaluation (ODE), Center for Devices and Radiological Heath (CDRH), Food and Drug Administration.  Ms. Shulman has been with CDRH since 1984.  Before serving on the 510(k) Staff she was on the Premarket Approval Staff.  Ms. Shulman is also the Reclassification/Classification Coordinator for CDRH.  Some of her accomplishments include drafting guidance documents and regulations regarding the 510(k) program, training staff, and assisting in the implementation of the Medical Device User Fee Modernization Act (MDUFMA), FDA Modernization Act (FDAMA) and the Food and Drug Administration Safety and Innovation Act (FDASIA). Ms. Shulman has been on numerous policy setting groups within the FDA.  Most recently she has been very active with the 510(k) Working Group whose mission it is to evaluate the 510(k) program and explore actions CDRH could take to enhance 510(k) decision making, 21st Century Cures and reauthorization of  MDUFMA. Ms. Shulman received her undergraduate degree from the University of Maryland, University College, and received her MBA from Hood College in May 1997.